Annovis Bio Prices $21 Million Public Offering

Bitget2026/11/05 13:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Annovis Bio priced a $21 million public offering, including 19,000,000 common shares at $1 each with an accompanying warrant.
Pre-funded warrants cover 2,000,000 shares at $0.9999 each with an accompanying warrant, in lieu of common shares.
Accompanying warrants cover 21,000,000 shares, are immediately exercisable at $1 per share and expire five years from issuance.
Pre-funded warrants carry a $0.0001 exercise price per share, are immediately exercisable and remain exercisable until exercised in full.
Closing expected November 6, 2026; proceeds fund buntanetap clinical studies, working capital and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611050805PRIMZONEFULLFEED9871182) on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Annovis Bio Prices $21 Million Public Offering

You may also like

Crypto prices